Granules News and Updates

Name: Latest research reports of Granules India Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Granules India Ltd.
Rating: 4
Author: Geojit BNP Paribas

Keep track of all breaking news on Granules from all sources in a single place.

Load latest

Granules India Ltd.

09 Mar 2025

571.60

-0.50%

USFDA flags Granules India for storage, equipment lapses at Telangana plant

Business Standard

The US health regulator has pulled up Granules India for failing to maintain buildings for drug storage and avoiding adequate procedures regarding cleaning and maintenance of equipment at its Telangana-based formulations plant. In a warning letter to the company's Chairman and Managing Director Krishna Prasad Chigurupati, the US Food and Drug Administration (USFDA) stated that the company failed to establish and follow adequate written procedures for maintaining equipment at the Medchal-Malkajgiri-based manufacturing facility. The USFDA inspected the facility from August 26 to September 6, 2024. "Our investigators observed significant contamination in multiple ducts of non-dedicated use in the preparation of finished drug products manufactured at your facility," the USFDA stated. While filters were installed to prevent contamination, inadequate cleaning and maintenance processes rendered them ineffective, it added. "Swab samples collected from the ducts by your firm during the...

Number of FII/FPI investors decreased from 199 to 189 in Sep 2025 qtr

USFDA rebukes Granules India for lapses in maintaining storage facilities, equipment at Telangana plant

Business Line | 09 Mar 2025

Granules India Ltd.

05 Mar 2025

571.60

-0.50%

Granules India Fails To Follow US FDA Mandated Safety Procedures

NDTV Profit

The US FDA said there were violation of current good manufacturing practice regulations for finished pharmaceuticals, at Granules India's Gagillapur facility.

Granules India Ltd. has an average target of 632.00 from 4 brokers.

Granules India Ltd.

04 Mar 2025

571.60

-0.50%

LIC raises stake in Granules India to 5.02%. Do you own?

livemint

Granules India share price has declined by 16.55% over the past month and over 20% on a year-to-date (YTD) basis. In the last six months, the pharma stock has dropped more than 32%.

Mutual Funds have decreased holdings from 12.24% to 6.54% in Sep 2025 qtr

Granules India Ltd.

28 Feb 2025

571.60

-0.50%

Granules India shares tumble almost 8% after USFDA issues warning letter for its Gagillapur facility

livemint

Granules India's shares fell nearly 8% after the US FDA issued a warning letter regarding its Gagillapur facility, citing four concerns. The company confirmed progress in addressing these issues while maintaining product distribution.

Number of FII/FPI investors decreased from 199 to 189 in Sep 2025 qtr

Granules India Share Price Hits Over Eight-Month Low After US FDA Issues Warning

NDTV Profit | 28 Feb 2025

Granules India Ltd.

21 Feb 2025

571.60

-0.50%

Granules India Acquires Swiss CDMO Firm Senn Chemicals AG For CHF 20 Million

NDTV Profit

The acquisition is expected to be completed in the first half of 2025, Granules India said in a statement.

Granules India Ltd. has an average target of 632.00 from 4 brokers.

Granules acquires Swiss firm for Rs 192 crore; forays into CDMO space

Business Standard | 21 Feb 2025

Granules India Ltd.

21 Feb 2025

571.60

-0.50%

Granules India to acquireSenn Chemicals AG for 192 crore

Business Line

Granules India Ltd. has an average target of 632.00 from 4 brokers.

Granules India Ltd.

17 Feb 2025

571.60

-0.50%

GRANULES INDIA

Accumulate: Granules India Ltd.

Target

Geojit BNP Paribas

Granules India Ltd. is trading above all available SMAs

Granules India Ltd.

30 Jan 2025

571.60

-0.50%

Granules India gets USFDA's nod forADHD generic

Business Line

With this latest approval, Granules India Ltd Limited now holds a total of 69 ANDA approvals, with 38 secured under the name of Granules India Limited (GIL) and 31 under Granules Pharmaceuticals, Inc. (GPI)

Mutual Funds have decreased holdings from 12.24% to 6.54% in Sep 2025 qtr

Granules India Gets USFDA Nod For Capsules That Treat ADHD

NDTV Profit | 30 Jan 2025

Granules India Ltd.

28 Jan 2025

571.60

-0.50%

Granules India To Offset Gagillapur Facility Delays With New Europe, US Launches

NDTV Profit

Approvals for four new launches from Granules's US facility have been secured and the fifth approval is awaited.

Number of FII/FPI investors decreased from 199 to 189 in Sep 2025 qtr

Granules India Ltd.

25 Jan 2025

571.60

-0.50%

Finished dosages remain the key earnings driver

Buy: Granules India Ltd.

Target

Motilal Oswal

Granules India (GRAN) delivered better-than-expected revenue, while EBITDA/PAT stood in line for the quarter. The traction in finished dosage (FDF) remained robust for six quarters now.